NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes - Wikidata - wikimedia - TriplyDB

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

http://www.wikidata.org/entity/Q28190347

about

sameAs

Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders Therapeutic effects of nitric oxide-aspirin hybrid drugs Insulin resistance, a new target for nitric oxide-delivery drugs.Recent developments in nitric oxide donor drugs.Review: Antiplatelet drugs: what comes next?Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages.Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.

P2860

Q24672983-A2367DBA-EDA6-4AE5-8900-156C3AC0B3F1 Q28200449-E52A9DB3-FCC2-4F56-857D-A7ED0F49A561 Q28210282-16B9CA49-C408-41C7-ACAE-C380C01301C7 Q35103203-80F947F6-76DD-4398-AE12-815CF824ECAD Q36052815-43AB9FE5-451A-4C05-BA07-97081F970A76 Q37809630-CBD88821-7546-4C8B-9F27-AEBC1085173A Q38558587-5F3C0EE3-284C-4E22-A5FC-85946CB96C71 Q42417725-4180B157-54B2-4737-BFE8-185E7697CC4E Q42667008-5FECBB74-3BBC-4352-AC59-4C3B1EA88C1F

P2860

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

http://www.wikidata.org/entity/Q28190347

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

@ast

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

@en

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

@nl

type

label

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

@ast

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

@en

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

@nl

prefLabel

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

@ast

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

@en

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

@nl

P1433

Q28190347-D6893CBB-8E64-4F9E-B13C-2276E68A3C0B

P1476

Q28190347-0F02B009-8662-4272-B88F-422608AAC9FD

P2093

Q28190347-1B7DA255-9F27-4A50-AB02-9DB041F7772A

Q28190347-297E2C45-07A7-4E93-87E9-EAEAD5EDB146

Q28190347-2E3B2192-32A9-4B90-A7E8-EE1E73038247

Q28190347-44537D8B-7E22-4F05-8AF4-31062851C91C

Q28190347-5235D95B-30D9-4E3F-97CB-53530C1FEB2E

Q28190347-6E898899-7C01-4B4F-946E-12D40854A0B7

Q28190347-A97416F6-BF0C-4BF1-96C0-C9CC71C87CEB

Q28190347-BA029DA5-A222-46E3-BD1B-F0574080994A

P2860

Q28190347-07453AAA-2F22-412F-A184-C79DED4EE0FD

Q28190347-1322242E-79E6-481F-B222-89FDBD13439F

Q28190347-3953E20B-DC69-4300-8860-3BFA43EEFA54

Q28190347-3BC8F4DB-5A04-4FFB-8C06-1E1FC487ED47

Q28190347-45FDDF45-29B3-4EDC-88E9-3A3F284852D5

Q28190347-633EBE1E-E0E1-4934-8209-EEFAE8CA23E7

Q28190347-63E81398-6C4E-48F4-B58A-8F68B16C0D02

Q28190347-8E0EF329-B97A-45D4-8B37-7A74B926B3AB

Q28190347-A78476A8-F264-4C6B-B180-B07EB176226E

Q28190347-BC1CD722-5CB2-45D1-AD8D-638A04AD68C1

P304

Q28190347-EDF3A99C-0AF4-4DAC-816A-4BA1CCA34783

P31

Q28190347-C770B859-A6C0-49EE-BFA2-A4BF2F341BAB

P356

Q28190347-13D94EA2-9E6A-4001-A52F-4AA248A918A6

P407

Q28190347-8229F5BA-B485-456D-8B4A-43F206BD616A

P433

Q28190347-F5CD2175-9564-4B0A-A951-AF2730485200

P478

Q28190347-CECF080A-A09F-412F-ABE1-E96D3C54D182

P577

Q28190347-D0F3F43F-3E3E-4064-80D4-3C5AEE226834

P5875

Q28190347-8579C174-AA0D-491A-97C9-371EA81A5B4E

P698

Q28190347-4491BA44-A9E7-4BA1-A47D-B10275C6C299

P921

Q28190347-026ACA28-9A7E-4FE8-85FC-9A43033CDB57

P932

Q28190347-546095C7-9FFA-44CB-B3FC-1C576B9B2D6E

P356

P1433

British Journal of Pharmacology

P1476

NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes

@en

P2093

A Lechi

http://www.w3.org/2001/XMLSchema#string

A Meneguzzi

http://www.w3.org/2001/XMLSchema#string

C L Santonastaso

http://www.w3.org/2001/XMLSchema#string

M Degan

http://www.w3.org/2001/XMLSchema#string

P D Soldato

http://www.w3.org/2001/XMLSchema#string

P Minuz

http://www.w3.org/2001/XMLSchema#string

S Gaino

http://www.w3.org/2001/XMLSchema#string

V Zuliani

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis — An Inflammatory Disease

The nitroderivative of aspirin, NCX 4016, reduces infarct size caused by myocardial ischemia-reperfusion in the anesthetized rat

NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes.

Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice.

Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid.

Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.

P304

905-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0704326

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11744879

http://www.w3.org/2001/XMLSchema#string

P698

11606332

http://www.w3.org/2001/XMLSchema#string

P921

P932

1573016

http://www.w3.org/2001/XMLSchema#string